Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis

BACKGROUND: Gastro esophageal reflux (GER) is common in cystic fibrosis (CF) and may contribute to lung disease. Approximately 50% of patients with cystic fibrosis are being treated with proton pump inhibitors (PPIs). METHODS: In a randomized controlled study in adults, we compared treatment with es...

Descripción completa

Detalles Bibliográficos
Autores principales: DiMango, Emily, Walker, Patricia, Keating, Claire, Berdella, Maria, Robinson, Newell, Langfelder-Schwind, Elinor, Levy, Diane, Liu, Xinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931289/
https://www.ncbi.nlm.nih.gov/pubmed/24528942
http://dx.doi.org/10.1186/1471-2466-14-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931289/
https://www.ncbi.nlm.nih.gov/pubmed/24528942
http://dx.doi.org/10.1186/1471-2466-14-21

Ejemplares similares